Request Trial

Marisa Woutersen

Key details

Marisa Woutersen is a senior reporter for Life Sciences Intellectual Property Review and World IP Review. She largely covers intellectual property developments across the global life sciences sector, including pharmaceuticals, biotechnology, medtech, AI, M&A and regulation.

Since joining Newton Media in 2023, Marisa has reported across a wide range of topics, from the rise of generative AI and its impact on the creative industries to the crossover between intellectual property and sport, including issues affecting athletes, as well as global pharmaceutical disputes, vaccine technology, access to medicines and life sciences M&A.

She has reported live from court and regularly travels to international conferences, where she interviews lawyers, business leaders and other key industry figures.

Marisa holds a Master’s in International Law and a BA in Politics and International Relations from the University of Sussex, and is currently completing her NCTJ Diploma in Journalism.

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine search
Total results: 456

Articles by Marisa Woutersen

Novo Nordisk India strategy suffers semaglutide patent setback
Asia
Novo Nordisk India strategy suffers semaglutide patent setback
The Delhi High Court has denied an injunction against an Indian generic manufacturer, finding credible challenges to the validity of Novo's semaglutide patent—flagging concerns over obviousness, double patenting, and evergreening.   4 December 2025
FedCirc voids Seagen patent in $41m cancer treatment dispute
Americas
FedCirc voids Seagen patent in $41m cancer treatment dispute
The appeals court reversed a jury verdict, finding the antibody-drug conjugate patent lacked adequate written description and enablement support from its priority application.   3 December 2025
New IP guidance promises to transform the NHS. Will it deliver?
Europe
New IP guidance promises to transform the NHS. Will it deliver?
The move could unlock billions in life sciences collaborations and position the UK to rival the US and China. But turning a famously conservative, patient-safety-first institution into a commercially savvy innovation hub will be no small feat.   2 December 2025
Europe
UPC draws hard line on urgency in first SPC dispute
The Paris Local Division says Merz ran out of time to stop Viatris' multiple sclerosis generic, clarifying the court’s urgency standards in the process.   1 December 2025
Europe
Patent and SPC litigator makes the move from Carpmaels
Joining an expanding IP litigation practice, the new partner adds experience in patent, SPC and multi-jurisdictional disputes across pharma, technology, and medical devices.   1 December 2025
Europe
UPC appeals court hands Amgen a win in cholesterol dispute
The Court of Appeal has overturned a ruling that revoked the pharma company’s cholesterol-lowering antibody patent, clarifying key principles for assessing inventive step.   27 November 2025
Careers
Ex-Teva counsel and FDA regulatory specialist returns to private practice
A regulatory counsel with nine years at the FDA and over two decades of patent experience has joined a firm in Washington, DC.   24 November 2025
Europe
What people talked about at London Life Sciences Week
The week exposed fractures in the UK's industry—but also unexpected reasons for optimism. Five themes dominated conversations about the direction of the country's life sciences sector.   21 November 2025
Europe
NHS updates outdated IP rules in bid to revive UK life sciences
The country’s public health service has replaced its IP framework with a nine-step plan, as the government tries to reposition the UK as a global life sciences leader.   20 November 2025
Americas
Sandoz wins Fed Circ reversal of $39m hair loss patent verdict
The court rules that Duke University and Allergan’s patent lacked sufficient written description, in the wake of stricter post-Amgen Section 112 standards.   19 November 2025

Not finding what you're looking for, please try resetting your applied search and filters,
or try the full site search.